Calamos Advisors LLC Incyte Corp Transaction History

Calamos Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 27, 2020	SELL	$74.18 - $108.93 $6.28 Million - $9.23 Million	-84,700 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$63.18 - $85.97 $5.05 Million - $6.88 Million	80,000 Added 1702.13%	84,700 $6.2 Million
Q3 2019 Oct 21, 2019	SELL	$72.82 - $86.52 $10,922 - $12,978	-150 Reduced 3.09%	4,700 $349,000
Q2 2019 Aug 07, 2019	BUY	$73.52 - $88.7 $356,572 - $430,195	4,850 New	4,850 $412,000
Q2 2018 Jul 17, 2018	SELL	$60.85 - $83.98 $1.4 Million - $1.94 Million	-23,047 Closed	0 $0
Q1 2018 Apr 13, 2018	BUY	$83.06 - $100.98 $90,784 - $110,371	1,093 Added 4.98%	23,047 $1.92 Million
Q4 2017 Feb 13, 2018	SELL	$93.56 - $116.6 $9.43 Million - $11.7 Million	-100,745 Reduced 82.11%	21,954 $2.08 Million
Q3 2017 Oct 25, 2017	BUY	$109.15 - $138.27 $1.04 Million - $1.32 Million	9,567 Added 8.46%	122,699 $14.3 Million
Q2 2017 Aug 09, 2017	BUY	N/A	113,132	113,132 $14.2 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.